MegaMD메가엠디
133750 · KOSDAQ · ₩133750 · 메가엠디
₩1,239▼ ₩31 (2.44%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩35B | ₩31B | ₩29B | ₩56B | ₩72B |
| Cost of sales | ₩14B | ₩12B | ₩12B | ₩21B | ₩26B |
| Gross profit | ₩21B | ₩19B | ₩17B | ₩35B | ₩46B |
| Operating income | ₩1.8B | ₩1.6B | −₩2.8B | ₩4.4B | ₩11B |
| Net income | ₩2.8B | ₩3.1B | −₩4.1B | ₩1.9B | ₩9.8B |
| Net income to shareholders | ₩2.8B | ₩3.1B | −₩4.1B | ₩1.9B | ₩9.8B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩83B | ₩93B | ₩89B | ₩97B | ₩119B |
| Current assets | ₩42B | ₩43B | ₩47B | ₩50B | ₩65B |
| Cash and equivalents | ₩12B | ₩30B | ₩29B | ₩32B | ₩31B |
| Total liabilities | ₩17B | ₩19B | ₩18B | ₩21B | ₩42B |
| Current liabilities | ₩15B | ₩16B | ₩14B | ₩16B | ₩38B |
| Borrowings | ₩1.2B | ₩1.2B | ₩2.1B | ₩2.7B | ₩3.4B |
| Total equity | ₩66B | ₩74B | ₩71B | ₩76B | ₩77B |
| Shareholders' equity | ₩66B | ₩74B | ₩71B | ₩76B | ₩77B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩5.1B | ₩9.1B | ₩3.9B | −₩7.1B | ₩19B |
| Capital spending | ₩1.3B | ₩282M | ₩2.5B | ₩1.3B | ₩1.9B |
| Free cash flow | ₩3.8B | ₩8.8B | ₩1.4B | −₩8.5B | ₩17B |
| Dividends paid | ₩1.3B | ₩0 | ₩0 | ₩3.3B | ₩2.2B |
Consolidated where available. Amounts in won.
Also known as: MegaMD / 메가엠디 / 133750 / KRX:133750
Source: KRX statistical information